Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles

Author(s)
Youngsaye, Willmen; Dockendorff, Chris; Hartland, Cathy L.; Bittker, Joshua A.; Dandapani, Sivaraman; ... Show more
Thumbnail
DownloadLIndquist_Overcoming fluconazole.pdf (583.0Kb)
OPEN_ACCESS_POLICY
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
Continuing efforts to discover novel means of combating fluconazole resistance in Candida albicans have identified an indole derivative that sensitizes strains demonstrating resistance to fluconazole. This tetracycle (3, ML229) does not appear to act through established Hsp90 or calcineurin pathways to chemosensitize C. albicans, as determined in Saccharomyces cerevisiae models, and may be a useful probe to uncover alternative resistance pathways.
Date issued
2012-05
URI
http://hdl.handle.net/1721.1/84955
Department
Massachusetts Institute of Technology. Department of Biology; Whitehead Institute for Biomedical Research
Journal
Bioorganic & Medicinal Chemistry Letters
Publisher
Elsevier B.V.
Citation
Youngsaye, Willmen, Chris Dockendorff, Benjamin Vincent, Cathy L. Hartland, Joshua A. Bittker, Sivaraman Dandapani, Michelle Palmer, et al. “Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles.” Bioorganic & Medicinal Chemistry Letters 22, no. 9 (May 2012): 3362-3365.
Version: Author's final manuscript
ISSN
0960894X
Collections